The Effects of Seonghyangjeonggisan on Cytokines Production in the Peripheral Blood Mononuclear Cells of Acute Cerebral Infarction Patients

  • Yun Jong Min (Department of Third Medicine, Professional Graduate School of Oriental Medicine, Wonkwang University, Department of Internal Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Lee Min Goo (Department of Third Medicine, Professional Graduate School of Oriental Medicine, Wonkwang University, Department of Internal Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Park Sae Wook (Department of Third Medicine, Professional Graduate School of Oriental Medicine, Wonkwang University, Department of Internal Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Lee In (Department of Internal Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Cho Kwang Ho (Department of Third Medicine, Professional Graduate School of Oriental Medicine, Wonkwang University, Department of Weurology, College of Pledicine, Wonkwang University) ;
  • Moon Byung Soon (Department of Third Medicine, Professional Graduate School of Oriental Medicine, Wonkwang University, Department of Internal Medicine, College of Oriental Medicine, Wonkwang University)
  • Published : 2004.08.01

Abstract

The Korean traditional medicine, Seonghyangjeonggisan (SHJGS) has long been used for acute cerebral infarction (Cl). However, scientific investigation has been carried out a little. Cytokines, involved in the regulation of inflammatory reactions and immune responses, may play an important role in the pathogenesis of Cl. The aim of this study is to investigate the effects of SHJGS on the production of various cytokines in the patients with acute Cl. Peripheral blood mononuclear cells (PBMC) obtained from the patients with acute Cl were cultured for 24hr in the presence or absence of lipopolysaccharide (LPS) and phytohaemagglutinin (PHA). The amount of TNF-α, IL-1β, IL-6 and IL-8, in PBMC culture supernatant, was significantly increased in the LPS and PHA treated cells, compared with unstimulated cells (P<0.05). This study showed that increased TNF-α, IL-1β, IL-6 and IL-8 level stimulated by LPS and PHA was inhibited by SHJGS (0.01-1 ㎎/㎖) in a dose-dependent manner but IL-8 level was not inhibited significantly at 1㎎/㎖ (P>0.05). The maximal inhibition rate of TNF-α, IL-1β, IL-6 and IL-8 by SHJGS (1㎎/㎖) was 68% (P<0.05), 53.9% (P<0.05), 45.5% (P<0.05), 46.7% (P>0.05) respectively. These results suggest that SHJGS might have anti-inflammatory effects through cytokine modulation. which might explain its beneficial effects in the treatment of acute Cl.

Keywords

References

  1. Zheng Zhi Yao Jue Dai Si Gong
  2. Zeung Maek Bang Yak Hap Pyun Hwang Do Yeon
  3. Proc Natl Acad Sci USA. v.94 Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction T Kawamata;WD Dietrich;T Schallert;JE Gotts;RR Cocke;LI Benowitz;SP Finklestein.
  4. Prog Neurobiol. v.56 Inflammation and glial responses in ischemic brain lesions G Stoll;S Jander;M Schroeter.
  5. Nature v.383 A functional diversity of helper T lymphocytes AK Abas;KM Murphy;A Sher.
  6. Immunol Today v.17 The expanding universe of T-cell subsets ; Th1, Th2 and more TR Mosmann;S Sad.
  7. Science v.272 The intrinsic role of innate immunity in the acquired immune response DT Fearon;RM Locksley.
  8. Annu Rev Immunol. v.13 Interleukin-12 ; a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity Trinchieri.
  9. Trends Neurosci. v.23 Interleukin 1 in the brain ; biology, pathology and therapeutic target NJ Rothwell;GN Luheshi.
  10. J Cereb Blood Flow Metab. v.18 Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1 beta in the rat RP Stroemer;NJ Rothwell.
  11. Neurosci Lett. v.249 Middle cerebral artery occlusion in the rat causes a biphasic production of immunoreactive interleukin-1 beta in the cerebral cortex EW Hillhouse;S Kida;F Iannotti.
  12. Mol Chem Neuropathol. v.23 Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia X Wang;TL Yue;FC Barone;RF White;RC Gagnon;GZ Feuerstein.
  13. Blood v.87 Biologic basis for interleukin-1 in disease CA Dinarello.
  14. Proc Natl Acad Sci USA. v.82 Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2) T Hirano;T Taga;N Nakano;K Yasukawa;S Kashiwamura;K Shimizu;K Nakajima;KH Pyun;T Kishimoto.
  15. Nature v.324 Complementary DNA for a novel human interleukin (BSF-2) that induces Blymphocytes to produce immunoglobulin T Hirano;K Yasukawa;H Harada;T Taga;Y Watanabe;T Matsuda;S Kashiwamura;K Nakajima;K Koyama;A Iwamatsu;S Tsunasawa;F Sakiyama;H Matsui;Y Takahara;T Taniguchi;T Kishimoto.
  16. Proc Natl Acad Sci USA. v.84 Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells Gauldie;C Richards;D Harnish;P Lansdorp;H Baumann.
  17. J Exp Med. v.168 Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients K Frei;TP Leist;A Meager;P Gallo;D Leppert;RM Zinkernagel;A Fontana.
  18. J Biol Chem. v.271 Indentification of defensin-1, defensin-2, and CAP37/Azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils O Chertov;DF Michiel;L Xu;JM Wang;K Tani;WJ Murphy;DL Longo;DD Taub;JJ Oppenheim.
  19. J Clin Invest. v.97 T lymphocyte recruitment by interleukin-8 (IL-8) DD Taub;M Anver;JJ Oppenheim;DL Longo;WJ Murphy.
  20. N Engl J Med. v.340 Atherosclerosis ; an inflammatory disease R Ross.
  21. Eur Heart J. v.21 Genetics of inflammation and risk of coronary artery disease ; the central role of interleukin-6 A Woods;DJ Brull;SE Humphries;HE Montgomery.
  22. J Biol Chem. v.281 Human tumor necrosis factor ; production, purification and characterization BB Aggrarwal;WJ Kohr;PE Hass;B Moffat;SA Spencer;WJ Henzel(et al.)
  23. Science v.83 Stroke-damaged neurons may commit cellular suicide M Bariniga.
  24. Proc Natl Acad Sci USA. v.339 Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium ; characterization and comparison with the actions of interleukin-1 P Bevilacqua;JS Pober;GR Majeau;RS Cotran;MA Gimbrone.
  25. Lancet v.10 Epidemiology of stroke R Bonita.
  26. Am J Neuroradiol. v.71 Correlation of angiographic and sequential CT findings in patients with evolving cerebral infarction L Bozzao;S Bastianello;LM Fantozzi;U Angeloni;C Argentino;C Fieschi.
  27. Neuroscience v.67 Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat M Buttini;K Appel;A Sauter;PJ Gebicke-Haerter;HW Boddeke.
  28. J Neurol Sci. v.19 Proinflammatory cytokines in serum of patients with acute cerebral ischemia ; kinetics of secretion and relation to the extent of brain damage and outcome of disease K Fassbender;S Rossol;T Kammer;M Daffertshofer;S Wirth;M Dollman(et al.)
  29. J Cereb Blood Flow Metab. v.6 Increased cytokine release from peripheral blood cells after acute stroke C Ferrarese;P Mascarucci;C Zoia;R Cavarretta;M Frigo;B Begni(et al.)